The National Institutes of Health (NIH), the US's premier biomedical research agency, has found itself at the center of a power struggle over institute directorships under the new administration. The agency, which employs 17,500 people, traditionally has few political appointees within its workforce, and its leadership selection process is often seen as non-partisan.
However, the Trump administration has taken steps to increase the number of political appointees at NIH, including placing nine individuals in key positions before the end of 2025. This shift has raised concerns among current and former officials about a new era of politicization within the agency.
NIH's institute directors are responsible for overseeing most of the funding decisions and day-to-day operations of the agency, making them critical to the Trump administration's agenda. Five of these directors were fired or placed on administrative leave in spring 2025, while another was appointed without any official announcement or background information.
The appointment process has been seen as compressed, with some insiders suggesting that the Trump administration is seeking to exert more control over NIH's leadership through appointments rather than search committees involving both career scientists and external experts. This approach has led to speculation about whether the agency will become more responsive to White House wishes while potentially losing its scientific expertise.
Lawmakers have taken notice of these changes, with some pushing for measures to protect NIH from political interference. A bill sponsored by Diana DeGette aimed to cap the number of political appointees at the agency and prevent politicization. Mark Histed, an NIH scientist, highlighted the importance of external search committees in preventing politicization.
The NIH's new leadership dynamics raise questions about its ability to conduct unbiased scientific research and balance competing interests. The Trump administration's actions have created a power struggle within the agency, which could impact the quality and direction of NIH's work for years to come.
However, the Trump administration has taken steps to increase the number of political appointees at NIH, including placing nine individuals in key positions before the end of 2025. This shift has raised concerns among current and former officials about a new era of politicization within the agency.
NIH's institute directors are responsible for overseeing most of the funding decisions and day-to-day operations of the agency, making them critical to the Trump administration's agenda. Five of these directors were fired or placed on administrative leave in spring 2025, while another was appointed without any official announcement or background information.
The appointment process has been seen as compressed, with some insiders suggesting that the Trump administration is seeking to exert more control over NIH's leadership through appointments rather than search committees involving both career scientists and external experts. This approach has led to speculation about whether the agency will become more responsive to White House wishes while potentially losing its scientific expertise.
Lawmakers have taken notice of these changes, with some pushing for measures to protect NIH from political interference. A bill sponsored by Diana DeGette aimed to cap the number of political appointees at the agency and prevent politicization. Mark Histed, an NIH scientist, highlighted the importance of external search committees in preventing politicization.
The NIH's new leadership dynamics raise questions about its ability to conduct unbiased scientific research and balance competing interests. The Trump administration's actions have created a power struggle within the agency, which could impact the quality and direction of NIH's work for years to come.